Electromedical Technologies and Nazarbayev University to Commence Landmark Alzheimer's Disease Research Program

Author's Avatar
Jul 29, 2021

•The Stage I research program now includes development of targeted Alzheimer's Disease therapy using bioelectronics •Experienced neuroscientist Dr. Sholpan Askarova to lead neuromodulation research program •Key objective is identification of electrical frequencies with a neuroprotection potency •Novel approach could emerge as alternative Alzheimer's Disease therapy to current, ineffective pharmaceuticals •Global therapy market is huge, estimated to reach $13.3 billion in 2023